Pharmafile Logo
Pharmafocus logo
Advanced Search

Quarter of the world may not access COVID-19 vaccine until 2022

December 16, 2020
Research and Development COVID-19, Vaccine

Almost a quarter of the world’s population may not have access to a COVID-19 vaccine until 2022, according to a …

News
abbvie_0

AbbVie buys COVID-19 antibody licence from Harbour BioMed

December 16, 2020
Research and Development AbbVie, COVID-19, Harbour BioMed, antibody

Harbour BioMed (HBM) and Utrecht University (UU) have announced that their fully human, SARS-CoV-2 neutralising antibody 47D11 and programme, has …

News
dw-anzcxqaqavhl

FDA panel backs Novartis’ Entresto for different form of heart disease

December 16, 2020
Research and Development FDA, Novartis, heart failure

Novartis’ heart failure drug Entresto has received recommendation from the FDA’s Cardiovascular and Renal Drugs Advisory Committee for use in …

News
lilly_building_with_american_flag_web

Eli Lilly scoops up gene therapy specialist Prevail Therapeutics for a potential $1.04bn

December 16, 2020
Research and Development, Sales and Marketing Eli Lilly, Prevail, acquisition

Eli Lilly has struck a deal to acquire Prevail Therapeutics in a transaction that could be valued at up to …

News

How COVID-19 is affecting diabetics and their access to insulin in America

December 15, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Diabetic patients face daily challenges of treatment access and treatment management, so 2020 has been a particularly challenging year. Conor …

Feature
astrazeneca_building_white

EMA panel recommends label extension of AstraZeneca’s Imfinzi in non-small cell lung cancer

December 15, 2020
Manufacturing and Production, Sales and Marketing AstraZeneca, Europe, Imfinzi, NSCLC

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has backed a new dosing regimen of AstraZeneca’s …

News
3500

UAE rolls out Sinopharm COVID-19 vaccine amid conflicting reports of efficacy

December 15, 2020
Manufacturing and Production, Research and Development COVID-19, China, Sinopharm, UAE, coronavirus

The United Arab Emirates has begun rolling out Sinopharm’s COVID-19 vaccine in its capital Abu Dhabi, despite claims that numerous …

News
reuters_-_tatyana_makeyeva_1

Final control point analysis shows 90% efficacy for Russia’s Sputnik V COVID-19 vaccine

December 15, 2020
Manufacturing and Production, Research and Development COVID-19, Sputnik V, Vaccine

Efficacy data have been revealed from the final control point data analysis for Russia’s Sputnik V COVID-19 vaccine, showing the …

News
1920px-city_of_london_skyline_from_london_city_hall_-_sept_2015_-_crop

New coronavirus strain identified in the UK

December 15, 2020
Manufacturing and Production, Research and Development COVID-19, UK, coronavirus, vaccines

A new variant of coronavirus has been identified in the UK, and is growing faster in some parts of England, …

News
image_3

PPAs – Ready to make a long-term commitment to zero carbon?

December 14, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Energy, sustainability

As an industry that consumes a large amount of energy, the pressure is on for the pharmaceutical sector to achieve …

News

PPAs – Ready to make a long-term commitment to zero carbon?

December 14, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Energy, sustainability

As an industry that consumes a large amount of energy, the pressure is on for the pharmaceutical sector to achieve …

News
Press release
fdaoutsideweb

FDA issues emergency use authorisation for Pfizer-BioNTech vaccine

December 14, 2020
Sales and Marketing COVID-19, FDA, US, Vaccine

The US Food and Drug Administration has approved the Pfizer-BioNTech COVID-19 vaccine for emergency use in those aged 16 and …

News
shutterstock_273326141

AstraZeneca to buy Alexion in $39 billion deal

December 14, 2020
Sales and Marketing Alexion, AstraZeneca, merger

British-Swedish AstraZeneca is set to acquire American biopharmaceutical company Alexion for $39 billion, in a move that will see a …

News
bavencio_merck_large

Pfizer and Merck KGaA secure CHMP recommendation for Bavencio in Europe for first-line maintenance of urothelial carcinoma

December 14, 2020
Sales and Marketing Bavencio, CHMP, EMA, Merck, Pfizer, pharma, urothelial carcinoma

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has given its recommendation for …

News
european_commission

European approval for AstraZeneca’s Trixeo Aerospace in moderate to severe COPD

December 14, 2020
Sales and Marketing AstraZeneca, COPD, EMA, Europe, Trixeo Aerosphere

The European Medicines Agency (EMA) has announced the approval of AstraZeneca’s Trixeo Aerosphere (formoterol fumarate/glycopyrronium bromide/budesonide) in the European Union …

News
shutterstock_95714119

Novartis and Incyte’s ruxolitinib fails to show benefit in COVID-19 at Phase 3

December 14, 2020
Research and Development, Sales and Marketing COVID-19, Incyte, Novartis

Novartis has unveiled that its JAK 1/2 tyrosine kinase inhibitor ruxolitinib fell short of its main efficacy goal in the …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

December 11, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, COVID-19, Pfizer, Vaccine, pharma, top 10

With just around three weeks until the end of a long year, rapidly emerging news around the leading COVID-19 vaccine …

News
spravato

Janssen’s esketamine nasal spray secures CHMP recommendation in Europe for the rapid reduction of depressive symptoms in a psychiatric emergency for patients with major depressive disorder

December 11, 2020
Medical Communications EMA, Europe, Spravato, depression

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has moved to recommend Janssen’s …

News
vaccination-1215279_960_720

Sanofi/GSK COVID-19 vaccine development delayed after failing to induce strong response in over-50s

December 11, 2020
Medical Communications, Research and Development COVID-19, GSK, Sanofi, Vaccine

Sanofi and GlaxoSmithKline have taken the decision to delay the development programme for their adjuvanted recombinant protein-based COVID-19 vaccine after …

News

FDA advisory panel recommends US approval of Pfizer/BioNTech’s COVID-19 vaccine

December 11, 2020
Medical Communications, Sales and Marketing COVID-19, FDA, Vaccine

An advisory panel on behalf of the FDA has strongly recommended that Pfizer and BioNTech’s COVID-19 vaccine BNT162b2 be approved …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025